Institute of Oncology Ljubljana

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

1 drugs in development

Preclinical1

By Therapeutic Area

top 1

Oncology

1100%

R&D Momentum

45/100

Pipeline Velocity

11/100

Trial Completion Rate

100/100

Pipeline Concentration

100/100

Pipeline Freshness

26/100

Activity

Recent Activity

Last 14 days

Jul 11, 2026

Active, not recruiting

Usefulness of Bioelectrical Impedance Analysis for Perioperative Fluid Evaluation and Complication Prediction in Oncological Patients Undergoing Colorectal Surgery

Jul 10, 2026

Active, not recruiting

Induction Versus Consolidation Chemotherapy in Total Neoadjuvant Therapy of Locally Advanced Rectal Cancer With High Risk of Recurrence (ICONA Study)

Earlier

Feb 3, 2026TrialEffect of Perioperative Intravenous Infusion of Lidocaine on the Postoperative Course and the Immune Response in Patients Undergoing Surgery for Colon Cancer - the PILDI Study

Sep 1, 2025TrialEffect of Perioperative Lidocaine or High-Dose Dexamethasone on Immune Response in Colon Cancer Surgery (PILDI Study)

Mar 31, 2024TrialIFN-Gamma Expression as a Predictor of Response to Immune Checkpoint Inhibitors in First-Line Metastatic Melanoma

Sep 1, 2023TrialTreatment of Post-radiation Xerostomia With Allogeneic Mesenchymal Stromal Stem Cells

Apr 1, 2023TrialPilot Study of Radiation-Induced Xerostomia Treatment With Allogeneic Mesenchymal Stromal Stem Cells

Oct 5, 2022TrialBiomarkers in Immunotherapy of Melanoma

4 more events

Apr 1, 2022TrialAnabolic Response To Intravenous Amino Acids In Chronic Intestinal Failure Patients

Mar 1, 2022TrialGastrointestinal Microbiome and Response to Immunotherapy in Metastatic Malignant Melanoma

Mar 1, 2022TrialImmunotherapy Efficacy and PD-L1 as a Predictive Biomarker in Metastatic Melanoma in Slovenia

Sep 28, 2021TrialIntratumoral phIL12 GET

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Pipeline

Drug Pipeline

Indication

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Oncology

Pancreatic Cancer

Standard First-Line Chemotherapy

Oncology

Pancreatic Cancer

Standard First-Line ChemotherapyPreclinical

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)